Kathleen Villa is the Executive Director of Medical Evidence Generation at Ionis Pharmaceuticals. In this role, she collaborates with cross-functional teams to evaluate unmet medical needs and generates data to help health care professionals make well-informed treatment decisions. Kathleen has over 20 years of experience as a pharma industry health economist and health outcomes researcher. Most of her roles have been in Medical Affairs, with additional experience in strategic planning, consulting, and digital health.

Kathleen was previously at Gilead Sciences where she developed and implemented the cross-functional Integrated Evidence Planning process across all therapeutic areas. She also led the Health Outcomes Research team at Evidation Health, spent several years as a health economist at Genentech supporting the Cardiovascular and Neuroscience TAs, and was the global head of Health Economics and Outcomes Research (HEOR) at Jazz Pharmaceuticals. Kathleen has expertise in observational research, health economic studies and modeling, survey research, patient-reported outcomes, and strategic evidence generation planning, and earned her MS in Evaluative Clinical Sciences at Dartmouth College.